---
title: "Bambusa Therapeutics surges 8%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/304894478.md"
description: "Bambusa Therapeutics rose 8.07% to US$17.00."
datetime: "2026-11-09T18:22:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/304894478.md)
  - [en](https://longbridge.com/en/news/304894478.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/304894478.md)
generator: "portal-rs"
---

# Bambusa Therapeutics surges 8%

Bambusa Therapeutics (BBTX.US) surged more than **8%** during regular trading to **$17.00**.

The Nasdaq Composite is little changed over the past five sessions.

The company completed an oversubscribed IPO on Oct. 30 at $16 per share, selling 10.6 million shares to raise $169 million.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [BBTX.US](https://longbridge.com/en/quote/BBTX.US.md)

## Related News & Research

- [Bambusa Therapeutics Director Helmut Wolfgang Jeggle Reports $6 Million Common Share Acquisition](https://longbridge.com/en/news/304008064.md)
- [Peter Kolchinsky and Rajeev Shah Disclose 14.6% Stake in Bambusa Therapeutics](https://longbridge.com/en/news/304691682.md)
- [BUZZ-Street View: Nvidia's AI story intact despite uncertainty at top](https://longbridge.com/en/news/305945171.md)
- [INSTANT VIEW-Nvidia earnings beat estimates; attention turns to call](https://longbridge.com/en/news/305875718.md)
- [Sandisk (SNDK) Stock Could Be 42% Below Fair Value Following Data Center Regulation Fears](https://longbridge.com/en/news/305917622.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**